MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ImmunoCellular Therapeutics Ltd Company Profile (NASDAQ:IMUC)

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NASDAQ:IMUC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (525.13% upside)

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NASDAQ:IMUC)
Show:
DateFirmActionRatingPrice TargetActions
3/13/2015Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Maxim GroupLower Price TargetBuy$4.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha